Macrophages in neovascular age-related macular degeneration: friends or foes?
about
Mechanisms of age-related macular degenerationMyeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in miceEvaluation of variants in the selectin genes in age-related macular degeneration.Complement component C5a activates ICAM-1 expression on human choroidal endothelial cellsCD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Development of gene therapy for treatment of age-related macular degeneration.Molecular mechanisms of subretinal fibrosis in age-related macular degeneration.Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degenerationMyeloid-Specific Blockade of Notch Signaling Attenuates Choroidal Neovascularization through Compromised Macrophage Infiltration and Polarization in MiceVascular associations and dynamic process motility in perivascular myeloid cells of the mouse choroid: implications for function and senescent change.Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.Oxidative stress, innate immunity, and age-related macular degenerationThe retinal pigment epithelium as a gateway for monocyte trafficking into the eye.Aging is not a disease: distinguishing age-related macular degeneration from aging.Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration.Loss of CD34 expression in aging human choriocapillaris endothelial cells.Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration.Understanding the role of aldose reductase in ocular inflammation.The immunological basis of degenerative diseases of the eye.PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema.Doyne lecture 2016: intraocular health and the many faces of inflammation.Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.Good news-bad news: the Yin and Yang of immune privilege in the eye.Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation).Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.Evaluation of C-reactive protein and CC-cytokine ligand 2 polymorphism interaction for age-related macular degeneration.Caffeine Prevents Blood Retinal Barrier Damage in a Model, In Vitro, of Diabetic Macular Edema.Human Vascular Endothelial Growth Factor A Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration
P2860
Q27000182-C5D27505-A37E-434A-8297-5F1A1CC19733Q27308666-8E999ABF-F790-4F7B-BD5A-60B6CB9AC38FQ33882331-6B4A9039-0274-450E-9FB1-E6D9497C60A7Q34735128-E4A4AA24-CCDA-43EC-BDA6-B5F5B216200DQ35028401-DC605D49-639E-4B87-BDA4-023615E1C419Q35118257-93E1A698-3DC1-422E-B5CF-7453597B5376Q35192906-0412A363-42AD-4540-853C-120E84CB5EC1Q35577823-FBF854B0-5336-435B-820B-E90DB57A76DEQ35865378-F4DA42D9-BC9A-4D97-AC9E-68B2F1E92C2CQ36060689-E8C12126-482D-4950-B414-DD896807A438Q36103357-6645B7E7-45F6-415F-8F76-603ACAE2A623Q36384723-B4978AC6-0178-4E00-96B7-EC193BDACD4DQ36940296-DA73721C-D468-4CC7-A1EC-B00922576504Q36954609-A7CDE6A4-75A4-44EA-86AD-EDD1935B7FD0Q37315838-A87555B6-9260-4714-A47E-5C05A729F0EAQ37397681-CCA155F1-8708-4362-9392-1C91ABE4457AQ37500428-66D3F178-7851-4092-AEAA-CDD6FCA9676EQ37547734-3A498BA5-4983-4E74-B851-EAFEE7C2728DQ37774015-26B0DB27-5677-4807-A47F-03D8D640EB3BQ38077553-BEDA5F83-060E-45D0-ADA9-F8FF2E6BCEAEQ38744168-69DB2642-B09E-4B4B-86DC-45C87253EEFFQ38754080-64585AC9-16CE-4D4D-A06C-80561B7A61D2Q38956279-BFA83657-6771-4BFC-A4C4-EFCFB7699B7AQ38975097-B583C0FC-8E5D-414A-8EE1-CA9B37E53C88Q41780299-B14660D1-9476-44A2-B5F5-D47F684FF866Q41856043-57C49CE9-DDF2-4480-B9ED-48867D42BF0CQ42186047-86C1796E-9F74-41C8-9F85-43C33D253493Q46466434-38D738A7-A4EB-4466-B064-DEA1FEDD63F4Q47993545-A1EB6332-9E1D-462A-8E79-DD029B1B620AQ58779270-B4BFF826-49A8-410B-84D5-F98B7EF0202B
P2860
Macrophages in neovascular age-related macular degeneration: friends or foes?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophages in neovascular age-related macular degeneration: friends or foes?
@en
Macrophages in neovascular age-related macular degeneration: friends or foes?
@nl
type
label
Macrophages in neovascular age-related macular degeneration: friends or foes?
@en
Macrophages in neovascular age-related macular degeneration: friends or foes?
@nl
prefLabel
Macrophages in neovascular age-related macular degeneration: friends or foes?
@en
Macrophages in neovascular age-related macular degeneration: friends or foes?
@nl
P2860
P356
P1433
P1476
Macrophages in neovascular age-related macular degeneration: friends or foes?
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2008.206
P577
2008-07-04T00:00:00Z